Jagsonpal Pharmaceuticals Limited has made a regulatory disclosure regarding the allotment of equity shares under its Employee Stock Option Plan (ESOP) 2022.
The Nomination and Remuneration Committee of the company has issued and allotted 27,950 equity shares of ₹2 each to eligible employees upon exercise of vested options under the JPL ESOP 2022. The allotment was made on August 24, 2026.
Financial and Capital Structure Impact
Consequent to this allotment, the company's paid-up share capital has increased from ₹13,18,58,940 (consisting of 6,59,29,470 equity shares of ₹2 each) to ₹13,19,14,840 (consisting of 6,59,57,420 equity shares of ₹2 each).
Share Details
The newly allotted shares will rank pari-passu with the existing equity shares of the company in all respects. The distinctive numbers of the shares range from 6,75,29,471 to 6,75,57,420. The ISIN number is INE048B01035.
Exercise Price Details
The shares were issued at varying exercise prices:
- ₹94.00 per share for 6,800 equity shares
- ₹113.60 per share for 6,750 equity shares
- ₹115.60 per share for 14,400 equity shares
- ₹92.00 per share for 6,800 equity shares
- ₹111.60 per share for 6,750 equity shares
- ₹113.60 per share for 14,400 equity shares